Isolated Hematuria with Myalgia and Normal Inflammatory Markers
The most likely diagnosis is a primary glomerular disorder (thin basement membrane nephropathy or IgA nephropathy), and you should proceed with urinalysis, urine microscopy for dysmorphic RBCs and RBC casts, renal function testing, and urine protein quantification, followed by nephrology referral for potential renal biopsy if glomerular disease is suspected.
Diagnostic Approach
The combination of hematuria with myalgia but normal ESR and CRP effectively excludes active systemic vasculitis and polymyalgia rheumatica, which characteristically present with markedly elevated inflammatory markers 1. The negative rheumatoid factor further argues against rheumatologic causes.
Initial Work-Up Priority
Start with distinguishing glomerular from non-glomerular hematuria:
Urine microscopy looking specifically for:
- Dysmorphic RBCs (>5% suggests glomerular origin)
- RBC casts (pathognomonic for glomerulonephritis)
- Proteinuria assessment (spot urine protein-to-creatinine ratio)
Serum creatinine and eGFR to assess renal function
Blood pressure measurement - hypertension with hematuria increases likelihood of mesangial proliferative glomerulonephritis over thin basement membrane nephropathy 2
Differential Diagnosis Based on Evidence
In patients with persistent isolated hematuria, the most common pathologies are 2:
- Thin basement membrane nephropathy (TBMN) - 49-55% of cases
- IgA nephropathy - 19-33% of cases (typically grade 2-3)
- Mesangial proliferative glomerulonephritis without IgA - 13% of cases
Key clinical discriminators 2:
- Elevated blood pressure or episodic macrohematuria → higher risk for mesangial proliferative GN rather than TBMN
- Severity of microhematuria does NOT correlate with pathological type
When to Pursue Renal Biopsy
Nephrology referral for biopsy consideration is warranted if:
- Proteinuria develops (>500 mg/day or protein-to-creatinine ratio >0.5)
- Hypertension emerges
- Renal function deteriorates
- Dysmorphic RBCs or RBC casts are present
Urologic Evaluation
Concurrent urologic work-up is necessary to exclude malignancy and structural causes 3:
- Cystoscopy - essential for bladder visualization
- Upper tract imaging (CT urography or renal ultrasound with retrograde pyelography)
- This is particularly important given that myalgia could represent referred pain from urologic pathology
Management Strategy
If Initial Work-Up is Negative
Close surveillance protocol 3, 2:
- Annual urinalyses for persistent asymptomatic microhematuria
- Repeat comprehensive evaluation within 3-5 years if hematuria persists
- Earlier re-evaluation if:
- Substantial increase in degree of hematuria
- Development of gross hematuria
- New proteinuria or hypertension
- Worsening myalgia or new symptoms
If Glomerular Disease is Confirmed
Most cases follow a benign clinical course 2. In a long-term follow-up study (mean 41 months), only 10 of 86 patients developed hypertension or proteinuria requiring intervention.
Monitor for progression indicators:
- Blood pressure at each visit
- Urine protein quantification every 6-12 months
- Serum creatinine annually
- Immediate intervention if proteinuria or hypertension develops
Critical Pitfalls to Avoid
Do not assume normal ESR/CRP rules out all systemic disease - however, it makes active inflammatory conditions highly unlikely at this moment
Do not attribute hematuria solely to myalgia/musculoskeletal causes - myoglobinuria from rhabdomyolysis would present with elevated creatine kinase and pigmented casts, not true hematuria 4
Do not delay urologic evaluation - even in younger patients, malignancy screening is essential with any hematuria 3
Do not perform renal biopsy prematurely - reserve for cases with proteinuria, hypertension, renal dysfunction, or clear evidence of glomerular disease on urinalysis 2